FIELD: medicine.
SUBSTANCE: invention refers to microbiology and molecular genetics, and concerns recombinant polypeptide StV, recombinant DNA stV coding the above recombinant polypeptide StV, recombinant plasmid DNA PQE-stV representing plasmid DNA PQE-30 carrying the above recombinant DNA stV, and the producing strain Escherichia coli M15-StV producing recombinant polypeptide StV.
EFFECT: presented inventions can be used in medical industry in producing Streptococcus agalactiae, eg Streptococci B vaccines.
4 cl, 6 dwg, 2 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
RECOMBINANT DNA ENSURING PRODUCTION OF RECOMBINANT PROTEIN PBI EXPRESSING PROTECTIVE PROPERTIES IN RELATION TO STREPTOCOCCUS PYOGENES AND STREPTOCOCCUS AGALACTIAE | 2008 |
|
RU2378374C2 |
COMPLEX OF RECOMBINANT POLYPEPTIDES WITH PROTECTIVE PROPERTIES IN RELATION TO STREPTOCOCCUS AGALACTIAE AND STREPTOCOCCUS PYOGENES | 2014 |
|
RU2587627C2 |
RECOMBINANT DNA PROVIDING PRODUCTION OF POLYPEPTIDES P6, P7, P8 EXHIBITING PROTECTIVE PROPERTIES AGAINST STREPTOCOCCUS AGALACTIAE AND SELECTIVELY CONNECTING IgA | 2008 |
|
RU2387715C2 |
METHOD FOR INTROGRESSION OF PATHOGENIC STREPTOCOCCUS GENES IN CHROMOSOMAL DNA OF PROBIOTIC STRAIN OF ENTEROCOCCUS FAECIUM L3 FOR EXPRESSION IN PILES | 2015 |
|
RU2640250C2 |
RECOMBINANT DNA ENSURING PRODUCTION OF THE RECOMBINANT PROTEIN COV1 EXHIBITING IMMUNOGENIC PROPERTIES AGAINST SARS-COV-2 VIRUS | 2021 |
|
RU2776484C1 |
CHIMERIC RECOMBINANT PROTEIN, HAVING PROTECTIVE PROPERTIES AGAINST STREPTOCOCCUS PYOGENES | 2016 |
|
RU2685957C2 |
RECOMBINANT DNA OF pG4223 AND PLASMID DNA PQE 30-pG4223, STRAIN OF ESCHERICHIA COLI M 15-G4223 WHICH ENABLE TO OBTAIN G4223 POLYPEPTIDE SELECTIVELY BINDING IgG, AND USE THEREOF IN AFFINE CHROMATOGRAPHY TO ISOLATE IgG | 2017 |
|
RU2715672C2 |
LIVE VACCINE BASED ON ENTEROCOCCUS FAECIUM L3 PROBIOTIC STRAIN FOR PREVENTION OF INFECTION CAUSED BY STREPTOCOCCUS PNEUMONIE | 2018 |
|
RU2701733C1 |
RECOMBINANT SWINE INFLUENZA VIRUS H1N1 VACCINE AND METHOD FOR PREPARING IT | 2010 |
|
RU2451027C2 |
METHOD FOR CREATING RECOMBINANT ENTEROCOCCUS L3-SARSN1 STRAIN BASED ON BIOLOGICALLY ACTIVE ENTEROCOCCUS FAECIUM L3 STRAIN | 2022 |
|
RU2820058C1 |
Authors
Dates
2015-02-20—Published
2012-05-17—Filed